TWILIGHT: Impact of Ticagrelor Alone vs. Ticagrelor Plus Aspirin on Ex-Vivo Blood Thrombogenicity in High-Risk Patients Undergoing PCI
Usman Baber, who led this thrombogenicity substudy, walks C. Michael Gibson through the key findings.
Listen to previous episodes | Download via iTunes
Brought to you by: Abbott